Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know by Claire M. Erickson, Nathaniel A. Chin, Sterling C. Johnson, Carey E. Gleason, Lindsay R. Clark

Get full text

Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort by Claire M. Erickson, Nathaniel A. Chin, Hannah L. Rosario, Amanda Peterson, Sterling C. Johnson, Lindsay R. Clark

Get full text

Communicating Alzheimer's biomarker results to cognitively unimpaired research participants: Satisfaction, utility, and impact on research attitudes by Claire M. Erickson, Fred B. Ketchum, Kristin E. Basche, Nathaniel A. Chin, Marcella L. Eveler, Lindsay R. Clark

Get full text

Comparing emergency department use among individuals with varying levels of cognitive impairment by Rebecca K. Green, Manish N. Shah, Lindsay R. Clark, Robert J. Batt, Nathaniel A. Chin, Brian W. Patterson

Get full text

Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values by Yue Ma, Derek L. Norton, Carol A. Van Hulle, Richard J. Chappell, Karen K. Lazar, Erin M. Jonaitis, Rebecca L. Koscik, Lindsay R. Clark, Rachel Krause, Ulf Andreasson, Nathaniel A. Chin, Barbara B. Bendlin, Sanjay Asthana, Ozioma C. Okonkwo, Carey E. Gleason, Sterling C. Johnson, Henrik Zetterberg, Kaj Blennow, Cynthia M. Carlsson

Get full text